Co-deposition of salmeterol and fluticasone propionate by a combination inhaler

International Journal of Pharmaceutics

Volumn 313, Issue 1-2, 2006, Pages 14-22

  Theophilus, Andrew ^a   Moore, Alison ^a   Prime, Dave ^a   Rossomanno, Simona ^a   Whitcher, Brandon ^a   Chrystyn, Henry ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Combination therapy; Fluticasone propionate; Salmeterol; Synergy

Indexed keywords

FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALMETEROL; SALMETEROL XINAFOATE;

ARTICLE; DRUG EFFICACY; DRUG FORMULATION; INHALER; METERED DOSE INHALER; METHODOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RAMAN SPECTROMETRY; STATISTICAL ANALYSIS;

ADRENERGIC BETA-AGONISTS; AEROSOLS; ALBUTEROL; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; DATA INTERPRETATION, STATISTICAL; DRUG COMBINATIONS; METERED DOSE INHALERS; SPECTRUM ANALYSIS, RAMAN;

EID: 33645275719     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.01.018     Document Type: Article

References (35)

1. I.M. Adcock, K. Maneechotesuwan, and O. Usmani Molecular interactions between glucocorticoids and long-acting beta2-agonists J. Allergy Clin. Immunol. 110 2002 S261 S268
2. S.K. Aggarwal, L.J. Frith, M. Ho, T.C. Weeks, and S.Y. Ho Fluticasone propionate/salmeterol delivered from a single inhaler demonstrates synergistic benefits in asthma Am. J. Respir. Crit. Care Med. 167 2003 A890
3. Andersen Samplers Inc. Operating Manual for Andersen 1 ACFM Non-Viable Ambient Particle Sizing Samplers, 1985. Published by Andersen Samplers Inc. Atlanta, GA, USA.
4. I.C. Ashurst, D. Prime, and P.A. Haywood Development of a dry powder inhaler device containing a combination of salmeterol and fluticasone propionate Eur. Respir. J. 12 1998 93s
5. M. Aubier, W. Pieters, N. Schlosser, and K.-O. Steinmetz Salmeterol/fluticasone propionate (50/500 mcg) in combination on a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid dependent asthma Respir. Med. 93 1999 876 884
6. J.N. Baraniuk, M. Ali, D. Brody, J. Maniscalco, E. Gaumond, T. Fitzgerald, G. Wong, A. Yuta, J.C. Mak, P.J. Barnes, R. Bascom, and T. Troost Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa Am. J. Respir. Crit. Care Med. 155 1997 704 710
7. P.J. Barnes Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids Eur. Respir. J. 19 2002 182 191
8. E.D. Bateman, M. Britton, J. Carrillo, J. Almeida, and C. Wixon Salmeterol/fluticasone (50/100 mcg) combination inhaler. A new, effective and well-tolerated treatment for asthma Clin. Drug Invest. 16 1998 193 201
9. E.D. Bateman, V. Silins, and M. Bogolubov Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 mcg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma Respir. Med. 95 2001 136 146
10. British Pharmacopoeia, 2002. General Monographs, Preparations for Inhalation.
11. British Guideline on the Management of Asthma, 2004. Update April 2004. http://www.brit-thoracic.org.uk/.
12. K.R. Chapman, N. Ringdal, V. Backer, M. Palmqvist, S. Saarelainen, and M. Briggs Salmeterol and fluticasone propionate (50/250 mcg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers Can. Respir. J. 6 1999 45 51
13. A.C. Davison, and D.V. Hinkley Bootstrap Methods and their Applications 1997 Cambridge University Press Cambridge, England
14. A. Emeryk, T. Bracomonte, U. Schauer, S. Balsara, and R. Athisegaran Efficacy of salmeterol/fluticasone propionate (50/100 mcg/day) delivered via the Diskus and MDI in children with asthma Eur. Respir. J. 22 2003 1985
15. D. Fraser Steele, P.M. Young, R. Price, T. Smith, S. Edge, and D. Lewis The potential use of Raman mapping to investigate deposition of combination pressurized metered-dose inhalers AAPS J. 6 2004 Article 21 (http://www.aapsj. org ).
16. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2003. Publication no. 2701. National Institutes for Health, Bethesda, 2001 (2003 update).
17. A.P. Greening, P. Ind, M. Northfield, and G. Shaw Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid Lancet 344 1994 219 224
18. Guidelines for the Diagnosis and Management of Asthma, 1997. Expert panel report 2. National Institutes of Health, National Heart, Lung and Blood Institute, July 1997. NIH publication number 97-4051.
19. M. Johnson Combination therapy for asthma: complementary effects of long-acting ß2-agonists and corticosteroids Curr. Allergy Clin. Immunol. 15 2002 16 22
20. S. Kirby, C. Falcoz, M.J. Daniel, S. Milleri, L. Squassante, L. Ziviani, and G.P. Ventresca Salmeterol and fluticasone propionate given as a combination: lack of systemic pharmacodynamic and pharmacokinetic interactions Eur. J. Clin. Pharmacol. 56 2000 781 791
21. J.C. Mak, M. Nishikawa, and P.J. Barnes Glucocorticosteroids increase B2-adrenergic receptor transcription in human lung Am. J. Physiol. 268 1995 L41 L46
22. T.R. Malley, I.C. Ashurst, G.E. Daniels, D. Prime, N.J. Stock, and P.A. Haywood Fine particle mass of a dry powder inhaler device containing a combination of salmeterol and fluticasone propionate Eur. Respir. J. 12 1998 8s
23. J. Matz, A. Emmett, K. Rickard, and C. Kalberg Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations J. Allergy Clin. Immunol. 107 2001 783 789
24. Y. Michael, M.J. Snowden, B.Z. Chowdhry, I.C. Ashurst, C. Davies-Cutting, and T. Riley Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system Int. J. Pharm. 221 2001 165 174
25. Miller, J.C., Miller, J.N., 1993. Statistics for Analytical Chemistry, 3rd ed. Ellis Horwood PRT Prentice Hall, Analytical Chemistry Series.
26. H. Nelson, K.R. Chapman, S.D. Pyke, M. Johnson, and J.N. Pritchard Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers J. Allergy Clin. Immunol. 112 2003 29 36
27. M. Roth, P.R. Johnson, J.J. Rudiger, G.G. King, Q. Ge, J.K. Burgess, G. Anderson, M. Tamm, and J.L. Black Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling Lancet 360 2002 1265 1266
28. S. Shrewsbury, S. Pyke, and M. Britton Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA) Br. Med. J. 320 2000 1368 1373
29. R.R. Sokal, and P.H. Sneath Principles of Numerical Taxonomy 1963 W.H. Freeman San Francisco
30. C. Swenson, J. Laseman, and W. Busse Combination of salmeterol (SAL) and Fluticasone (FP) works synergistically to inhibit airway inflammation post allergen challenge J. Allergy Clin. Immunol. 111 2003 S126
31. N.J. Van den Berg, M. Ossip, C.A. Hederos, H. Anttila, B.L. Ribeiro, and P.I. Davies Salmeterol/fluticasone propionate (50/100 mcg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma Paediat. Pulmonol. 30 2000 97 105
32. J.A. van Noord, H. Lill, T. Carrillo Diaz, A.P. Greefhorst, and P. Davies Clinical equivalence of salmeterol/fluticasone propionate combination product (50/500 g) delivered via a chlorofluorocarbon-free metered dose inhaler with the Diskus in patients with moderate to severe asthma Clin. Drug Invest. 21 2001 243 255
33. A. Woolcock, B. Lundback, N. Ringdal, and L.A. Jacques Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids Am. J. Respir. Crit. Care Med. 153 1996 1481 1488
34. P.M. Young, R. Price, S. Jones, and M. Parry-Billings Investigation into drug and excipient interaction in dry powder inhaler combination products Proc. Respir. Drug Deliv. IX 3 2004 749 752
35. O. Zetterström, R. Buhl, H. Mellem, M. Perpiñà, J. Hedman, S. O'Neill, and T. Ekstrom Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone Eur. Respir. J. 18 2001 262 268